These results suggest that TR might transcriptionally controls the Cyp8b1 expression through a super-enhancer-mediated mechanism
Doctors have been raising concerns for years that, while GLP-1 drugs have myriad benefits, they trigger such rapid weight loss that it's hard to preserve muscle or even have the energy to work out
But having diabetes also puts a person at increased risk for developing gastroparesis, so its difficult to know if the risks would look the same for people who dont have the condition
Telehealth consultations available throughout New York
Compared with other peptides with a similar receptor profile, retatrutide is being investigated as a compound with a broader range of activity across metabolic pathways, which is the subject of further research
(2025), and the European Journal of Pharmacology paper by Abdul-Rahman et al